10 Cambridge spinouts changing the story of cancer
17 October 202410 Cambridge spinouts on putting their research into practice to improve outcomes for cancer patients - and why Cambridge is a great place to do this.
10 Cambridge spinouts on putting their research into practice to improve outcomes for cancer patients - and why Cambridge is a great place to do this.
Seven Cambridge University researchers are among the 59 biomedical and health researchers elected to the Academy of Medical Sciences Fellowship.
Scientists at the University of Cambridge, in collaboration with Justus-Liebig University, Germany, have uncovered how the genome of SARS-CoV-2 - the coronavirus that causes COVID-19 - uses genome origami to infect and replicate successfully inside host cells. This could inform the development of effective drugs that target specific parts of the virus genome, in the fight against COVID-19.
Researchers have discovered that honey bees are able to share immunity with other bees and to their offspring in a hive by transmitting RNA ‘vaccines’ through royal jelly and worker jelly. The jelly is the bee equivalent of mother’s milk: a secretion used to provide nutrition to worker and queen bee larvae.
Evidence has been building in recent years that our diet, our habits or traumatic experiences can have consequences for the health of our children – and even our grandchildren. The explanation that has gained most currency for how this occurs is so-called ‘epigenetic inheritance’ – patterns of chemical ‘marks’ on or around our DNA that are hypothesised to be passed down the generations. But new research from the University of Cambridge suggests that this mechanism of non-genetic inheritance is likely to be very rare.
A benefactor of the University of Cambridge, Leonard Blavatnik, has made a multi-million pound pledge to provide funding for Israeli scientists of outstanding ability to study in Cambridge.